Posterior Pole Asymmetry Analysis (PPAA) for Early Glaucoma

Spectrailis optical coherence tomography has come with a new posterior pole asymmetry analysis for glaucoma diagnosis. The aim of the investigators study was to assess its applicability in diagnosing early glaucoma patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Age range

49 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Dr TV Patel Eye Institute

Vadodara, Gujarat, 390001, India

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age more than 18 years
Best corrected visual acuity 20/40 or better
Refractive error within ±5D sphere and ±3D cylinder
Willingness to participate in the study

Exclusion criteria

Media opacities preventing imaging
Intraocular surgery within the last 6 months
Any retinal or neurological disease other than glaucoma that could confound the results of visual field examination and OCT.

Treatment and study plan

Primary outcomes

Area under curve for all the diagnostic parameters of optical coherence tomography

Time frame: up to 32 weeks

This was a cross sectional study with one time measurement of the diagnostic parameters of the optical coherence tomography.

Sponsors and collaborators

Lead sponsor

Dr T V Patel Eye Institute

Other

Registry information

Official study title

Diagnostic Ability of Posterior Pole Asymmetry Analysis Parameters (PPAA) of Spectralis Optical Coherence Tomography (OCT) in Detecting Early Glaucoma

Acronym: PPAA

Important dates

Study start: 2013
Primary completion: 2014
Study completion: 2014
First posted: May 19, 2014
Registry last updated: May 19, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed